These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18837038)

  • 1. Improved physical stability of amorphous state through acid base interactions.
    Telang C; Mujumdar S; Mathew M
    J Pharm Sci; 2009 Jun; 98(6):2149-59. PubMed ID: 18837038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
    Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
    Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
    Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.
    Ueda H; Aikawa S; Kashima Y; Kikuchi J; Ida Y; Tanino T; Kadota K; Tozuka Y
    J Pharm Sci; 2014 Sep; 103(9):2829-2838. PubMed ID: 24890320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of amorphous molecular dispersions of indomethacin and its sodium salt.
    Tong P; Zografi G
    J Pharm Sci; 2001 Dec; 90(12):1991-2004. PubMed ID: 11745758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
    Zhang GC; Lin HL; Lin SY
    J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T; Zografi G
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
    Konno H; Taylor LS
    J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures.
    Priemel PA; Laitinen R; Barthold S; Grohganz H; Lehto VP; Rades T; Strachan CJ
    Int J Pharm; 2013 Nov; 456(2):301-6. PubMed ID: 24012867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.
    Chauhan H; Kuldipkumar A; Barder T; Medek A; Gu CH; Atef E
    Pharm Res; 2014 Feb; 31(2):500-15. PubMed ID: 24122167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
    Kini A; Patel SB
    Pharm Dev Technol; 2017 Feb; 22(1):45-57. PubMed ID: 26853838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.